Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aaron E Foster

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Blood|July 3, 2004
Human CD62L- memory T cells are less responsive to alloantigen stimulation than CD62L+ naive T cells: potential for adoptive immunotherapy and allodepletionAaron E Foster, Marina Marangolo, Mary M Sartor, et al.
Nanoscale Research Letters|June 30, 2011
T cells enhance gold nanoparticle delivery to tumors in vivoLaura C Kennedy, Adham S Bear, Joseph K Young, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 16, 2010
T cells expressing constitutively active Akt resist multiple tumor-associated inhibitory mechanismsJiali Sun, Gianpietro Dotti, Leslie E Huye, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 9, 2008
Antitumor activity of EBV-specific T lymphocytes transduced with a dominant negative TGF-beta receptorAaron E Foster, Gianpietro Dotti, An Lu, et al.
Journal of Hematotherapy & Stem Cell Research|March 29, 2003
Rapid, large-scale generation of highly pure cytomegalovirus-specific cytotoxic T cells for adoptive immunotherapyAaron E Foster, David J Gottlieb, Marina Marangolo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 7, 2010
IRAK-M removal counteracts dendritic cell vaccine deficits in migration and longevityMeghan E Turnis, Xiao-Tong Song, Adham Bear, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 30, 2009
Genetic modification of T cells with IL-21 enhances antigen presentation and generation of central memory tumor-specific cytotoxic T-lymphocytesAnjum S Kaka, Donald R Shaffer, Ryan Hartmaier, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 26, 2007
Autologous designer antigen-presenting cells by gene modification of T lymphocyte blasts with IL-7 and IL-12Aaron E Foster, Ann M Leen, Timothy Lee, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 16, 2009
Optimization of the PiggyBac transposon system for the sustained genetic modification of human T lymphocytesYozo Nakazawa, Leslie E Huye, Gianpietro Dotti, et al.
Blood|May 18, 2007
Epstein Barr virus specific cytotoxic T lymphocytes expressing the anti-CD30zeta artificial chimeric T-cell receptor for immunotherapy of Hodgkin diseaseBarbara Savoldo, Cliona M Rooney, Antonio Di Stasi, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Blood|July 3, 2004
Human CD62L- memory T cells are less responsive to alloantigen stimulation than CD62L+ naive T cells: potential for adoptive immunotherapy and allodepletionAaron E Foster, Marina Marangolo, Mary M Sartor, et al.
Nanoscale Research Letters|June 30, 2011
T cells enhance gold nanoparticle delivery to tumors in vivoLaura C Kennedy, Adham S Bear, Joseph K Young, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 16, 2010
T cells expressing constitutively active Akt resist multiple tumor-associated inhibitory mechanismsJiali Sun, Gianpietro Dotti, Leslie E Huye, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 9, 2008
Antitumor activity of EBV-specific T lymphocytes transduced with a dominant negative TGF-beta receptorAaron E Foster, Gianpietro Dotti, An Lu, et al.
Journal of Hematotherapy & Stem Cell Research|March 29, 2003
Rapid, large-scale generation of highly pure cytomegalovirus-specific cytotoxic T cells for adoptive immunotherapyAaron E Foster, David J Gottlieb, Marina Marangolo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 7, 2010
IRAK-M removal counteracts dendritic cell vaccine deficits in migration and longevityMeghan E Turnis, Xiao-Tong Song, Adham Bear, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 30, 2009
Genetic modification of T cells with IL-21 enhances antigen presentation and generation of central memory tumor-specific cytotoxic T-lymphocytesAnjum S Kaka, Donald R Shaffer, Ryan Hartmaier, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 26, 2007
Autologous designer antigen-presenting cells by gene modification of T lymphocyte blasts with IL-7 and IL-12Aaron E Foster, Ann M Leen, Timothy Lee, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 16, 2009
Optimization of the PiggyBac transposon system for the sustained genetic modification of human T lymphocytesYozo Nakazawa, Leslie E Huye, Gianpietro Dotti, et al.
Blood|May 18, 2007
Epstein Barr virus specific cytotoxic T lymphocytes expressing the anti-CD30zeta artificial chimeric T-cell receptor for immunotherapy of Hodgkin diseaseBarbara Savoldo, Cliona M Rooney, Antonio Di Stasi, et al.
Pageof 5